Podcast: Play in new window | Download
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.
This week our hosts Lewis Goldberg and Phil Carlson are joined by Ken Belotsky and Hayim Raclaw of Negev Capital, an Israeli-based psychedelic medical intervention investment fund that targets companies that are at an early stage of clinical development.
In this conversation Ken and Hayim walk our hosts through Negev’s investing philosophy, their best and worst investment bets and what they learned from them, and how Israeli companies have the unique ability to punch above their weight in the biotech space.
So sit back and enjoy our conversation with Ken Belotsky and Hayim Raclaw, Principals of Negev Capital.
Links and mentions in the show
Links to the guest’s company and social media accounts
- Negev Capital’s LinkedIn: https://www.linkedin.com/company/negev-capital
- Ken Belotsky’s LinkedIn: https://www.linkedin.com/in/ibelotsky/
- Ken Belotsky’s Twitter: https://twitter.com/ibelotsky
- Hayim Raclaw’s LinkedIn: https://www.linkedin.com/in/hayim-raclaw-3393424/
- Hayim Raclaw’s Twitter: https://twitter.com/hayimraclaw
This episode was hosted by Lewis Goldberg and Phil Carlson of KCSA Strategic Communications.
Special thanks to our Program Director Shea Gunther.
This episode of The GreenRush is brought to you by Heffernan Insurance Brokers
You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa.com or emailing email@example.com. You can also connect with us via our social channels: